RA CAPITAL MANAGEMENT, L.P.
Q1 2025 13F Holdings
- Locationboston, MA
- Num holdings
85
- Value ($000)
$5,987,913
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001346824
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ASND ASCENDIS PHARMA A/S - ADR | SH | 04351P101 | $1.60B | 27 % | 10,281,496 | ||
PCVX VAXCYTE INC | SH | 92243G108 | $460.26M | 8 % | 12,189,149 | ||
RYTM RHYTHM PHARMACEUTICALS INC | SH | 76243J105 | $322.29M | 5 % | 6,084,412 | ||
JANX JANUX THERAPEUTICS INC | SH | 47103J105 | $302.12M | 5 % | 11,189,693 | ||
NEWAMSTERDAM PHARMA CO NV | SH | N62509109 | $207.54M | 4 % | 10,138,938 | ||
ACLX ARCELLX INC | SH | 03940C100 | $199.20M | 3 % | 3,036,527 | ||
EWTX EDGEWISE THERAPEUTICS INC | SH | 28036F105 | $196.00M | 3 % | 8,909,091 | ||
RNA AVIDITY BIOSCIENCES INC | SH | 05370A108 | $185.99M | 3 % | 6,300,408 | ||
WAVE LIFE SCIENCES LTD | SH | Y95308105 | $147.07M | 3 % | 18,202,009 | ||
ETNB 89BIO INC | SH | 282559103 | $144.60M | 2 % | 19,889,683 |
Rows Per Page
10
- 10
- 50
- 100